FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to a medicinal formulation with the constant rate for releasing a medicinal substance, core of medicinal formulation and to a method for providing relieved release of medicinal substance. Medicinal formulation comprises medicinal substance-containing layer and semi-permeable wall and expanding layer. A layer promoting to moving forward is placed between semi-permeable wall and medicinal substance-containing layer and the content of medicinal substance is at least 20% of the total layer mass containing a medicinal substance. Invention provides releasing practically all amount of medicinal substance from medicinal formulation to medium for it applying.
EFFECT: improved and valuable medicinal and pharmaceutical properties of medicinal formulation.
12 cl, 13 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND MEDICINAL FORMULATIONS FOR CONTROLLED DELIVERY OF PALIPERIDONE | 2003 |
|
RU2321391C2 |
| MEDICINAL CONTROLLED-RELEASING FORMS OF AZITHROMYCIN | 1995 |
|
RU2130311C1 |
| CONTROLLED-RELEASE HYDROCODON COMPOSITION | 2001 |
|
RU2253452C2 |
| ORAL DOSAGE FORMS OF TOFACITINIB WITH CONTINUOUS RELEASE | 2014 |
|
RU2790166C2 |
| ORAL PHARMACEUTICAL MEDICINAL FORM WITH DISCRETE RELEASE | 1998 |
|
RU2205028C2 |
| PROLONGED-RELEASE ORAL PHARMACEUTICAL MEDICINAL FORM | 1998 |
|
RU2214232C2 |
| DOSAGE FORMS WITH RETARDED RELEASE OF ZIPRASIDONE | 2004 |
|
RU2351316C2 |
| DEVICE FOR DELIVERING CURATIVE REMEDIES IN THE FORM OF SUSPENSION WITH CONTROLLABLE RELEASE | 1995 |
|
RU2168330C2 |
| TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS | 2014 |
|
RU2674345C2 |
| PREPARING DOSAGE FORMS OF CONTROLLED-RELEASE SKELETAL MUSCLE RELAXANT | 2009 |
|
RU2540494C2 |
